Beedimani, R. S., & Kalmath, B. (2017). Canagliflozin: a novel ‘glucuretic’ approach for the treatment of type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology, 3(3), 578–580. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1032